Jonathan Lim, M.D.

Physician-turned-venturepreneur who founds, funds and leads mission-driven ventures dedicated to revitalizing people, planet and perspective.

[Jonathan Lim, M.D. @JLimMD]

Are you a venturepreneur? #entrepreneur #venturecapital #leadership https://t.co/QNFjIu2fWs

[Jonathan Lim, M.D. @JLimMD]

#employeeappreciationday is a great opportunity to express how full my heart is with gratitude and appreciation for each of our Erascals’ dedication to our mission to #erasecancer https://t.co/rMexTcdbL3

[Jonathan Lim, M.D. @JLimMD]

@erasca's version of RTO.... https://t.co/JyRnLtESwJ

[Jonathan Lim, M.D. @JLimMD]

Congrats to Boundless Bio on successfully raising a Series B with such amazing investors. Looking forward to the company making a dent in #ecDNA driven tumors to benefit patients! https://t.co/QplsJPzEGB

[Jonathan Lim, M.D. @JLimMD]

We are thrilled to welcome Bihua and Julie to Erasca’s Board of Directors! #erasecancer https://t.co/lohiIC1Imo

[Jonathan Lim, M.D. @JLimMD]

Super excited about the future impact of ARCH Fund XI on new solutions for patients: https://t.co/etTO61SO3N

[Jonathan Lim, M.D. @JLimMD]

Erasca's 1st of multiple strategies to #erasecancer is a powerful MAPK Clamp vs. upstream & downstream nodes to shut down, or clamp, the signaling of RAS/MAPK oncogenic drivers trapped in between: https://t.co/8h8uOlJWhR

[Jonathan Lim, M.D. @JLimMD]

And congrats to Maze and BridgeBio on exciting Contour Therapeutics JV to bring precision medicine approach to fighting heart disease! https://t.co/mwWJmk0tQq

[Jonathan Lim, M.D. @JLimMD]

Congrats to Maze and Alloy on exciting Broadwing JV intended to help bring an end to blindness! https://t.co/ID5yznc2AK

[Jonathan Lim, M.D. @JLimMD]

Erasca team's expansion is requiring a new home to #erasecancer https://t.co/BeCir437xZ

[Jonathan Lim, M.D. @JLimMD]

It’s been amazing working with Mike Varney as part of the Erasca team. Thank you, NASDAQ, for this recognition! https://t.co/pRC5qiFKjG

[Jonathan Lim, M.D. @JLimMD]

The pandemic, wildfires, and other natural disasters are united by a root cause: Our activities are destroying nature. We must act to reverse this #environment #biodiversity #GlobalWarming https://t.co/nBqf9Q3ppp

[Jonathan Lim, M.D. @JLimMD]

Grateful to add Partner Fund and OrbiMed to our cause at Erasca: https://t.co/VvEUupqkd7

[Jonathan Lim, M.D. @JLimMD]

We are thrilled to have a biotech industry icon like Mike join us in our ambitious goal of erasing cancer. His distinguished career, culminating most recently in leading Genentech Research and Early Development, will bring invaluable expertise as we... https://t.co/vPbnVfx6GT

[Jonathan Lim, M.D. @JLimMD]

Millions of people still suffer from cancer daily. We @erasca are immensely grateful to have supportive Series B investors who embrace our mission to erase cancer. https://t.co/7Bx6fLDXEE

[Jonathan Lim, M.D. @JLimMD]

Grateful for all that our amazing #biotech ecosystem, including ARCH Venture and its portfolio, is doing to fuel #innovation during these unprecedented times https://t.co/yfPLx6023z

[Jonathan Lim, M.D. @JLimMD]

Check out my recent talk on 5 revolutions to erase cancer -- special thanks to a16z! https://t.co/h9zuQxsZ8J #oncology
#innovations

[Jonathan Lim, M.D. @JLimMD]

Congrats to Maze Tx and Black Diamond Tx on being named “Fierce 15” biotech companies for 2019! https://t.co/DQZIYWHCWW

[Jonathan Lim, M.D. @JLimMD]

Congrats to @BoundlessBio on today’s launch! Really excited to be a part of this mission to target ecDNA for the benefit of patients with cancer.

[Boundless Bio @BoundlessBio]

Today, we launched Boundless Bio with a mission to deliver transformative therapies to patients with difficult-to-treat cancers driven by extrachromosomal DNA (ecDNA). Learn more about who we are and what we do. https://t.co/5LMV19Y2hA

[Jonathan Lim, M.D. @JLimMD]

Excited to announce successful close of $64M Series A, with addition of ARCH and @a16z (see recent leadership team visit). Learn more: https://t.co/VaXQ1zyFuv - Now let’s go #erasecancer for patients!